Johnson Johnson (Brazil) Today
| JNJB34 Stock | BRL 62.18 0.32 0.51% |
Performance2 of 100
| Odds Of DistressLess than 9
|
Johnson Johnson is trading at 62.18 as of the 30th of November 2024, a 0.51% down since the beginning of the trading day. The stock's open price was 62.5. Johnson Johnson has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Johnson Johnson are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. The company was incorporated in 1887 and is based in New Brunswick, New Jersey. JOHNSON DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 39.22 B outstanding shares. More on Johnson Johnson
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Johnson Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Johnson Johnson's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Johnson Johnson or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Alex Gorsky |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Johnson Johnson (JNJB34) is traded on Sao Paulo Exchange in Brazil and employs 35 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.23 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Johnson Johnson's market, we take the total number of its shares issued and multiply it by Johnson Johnson's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Johnson Johnson operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 39.22 B outstanding shares.
Johnson Johnson has accumulated about 15.34 B in cash with 23.41 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78.
Check Johnson Johnson Probability Of Bankruptcy
Johnson Johnson Risk Profiles
Although Johnson Johnson's alpha and beta are two of the key measurements used to evaluate Johnson Johnson's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9097 | |||
| Semi Deviation | 1.1 | |||
| Standard Deviation | 1.21 | |||
| Variance | 1.45 |
Johnson Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Johnson Johnson without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Johnson Johnson Corporate Management
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk Brinckman | Chief Officer | Profile | |
| Robert Decker | Controller Officer | Profile | |
| Jessica Moore | VP Relations | Profile | |
| Joseph CPA | Ex CFO | Profile | |
| James Swanson | Ex Officer | Profile |
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Johnson Stock refer to our How to Trade Johnson Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..